patients with normal renal function (NRF), with chronic renal insufficiency (CRI) and dialysis dependent (DD) patients. The 9-month target lesion revascularization (TLR) rate was the primary endpoint whereas the 9-month major adverse cardiac events (MACE) and procedural success rates were part of the secondary endpoints.
FP551 REAL-TIME VOLUME ASSESSMENT Nephrology, University Hospital Galway, Galway, Ireland INTRODUCTION AND AIMS: Haemodialysis (HD) involves both removal of waste products and of excess water in patients with end-stage kidney disease (ESKD).. Appropriate volume removal by ultrafiltration (UF), is critical in this population and the process of determining the specifics of what volume to remove and over what timeframe can at times be difficult to determine. The inferior vena cava (IVC) is a central venous structure in the body which represents a pliable reservoir for circulating blood volume. Its use in assessing right atrial pressure (RAP) as a surrogate marker for central venous pressure (CVP) has been well-described, using IVC diameter (IVCd) and collapsibility index (IVCCI) as measured by echocardiography. CVP in turn is raised in conditions where circulating plasma volume is increased, such as heart failure or HDdependent renal failure.The aim of this study was to assess if detailed analysis of change in the IVC over a course of a dialysis session reflects changes in intravascular volume in response to UF using standard echocardiographic point-of-care assessment. METHODS: 20 patients were recruited in a prospective fashion over two hospital sites. Patients established on HD with a history of a stable UF prescription requiring at least 2 litres of volume removal per session were included. Ultrasound IVC measurements were taken at commencement (pre-dialysis), half-way through the anticipated duration of treatment (mid-dialysis) and at completion of therapy (post-dialysis). RESULTS: IVCmax, IVCmin, Hct and N-terminal B-type natriuretic peptide (NTproBNP) all changed significantly over the course of dialysis (see Table 1 ).Change in IVCmax and IVCmin over the three dialysis timepoints was not uniform. A steeper reduction in IVC diameter was noted during the first phase (pre-to mid-) when compared to the second phase (mid-to post-) -see Figure 1 .Significantly, the test was feasible in all cases. Patients participating in the study did not experience excessive discomfort or disruption to their dialysis schedule. CONCLUSIONS: IVCmax and IVCmin change significantly over the course of a dialysis session. IVC based measurements may prove a useful surrogate for determining appropriateness of volume removal. 
INTRODUCTION AND AIMS:
It has been previously reported that HD patients evidenced chronic elevation of cTn levels, leading to inconclusive interpretation of a single troponin (TnT) value above the 99th percentile. Therefore, serial measures of circulating cTn are needed to distinguish between acute coronary syndrome and chronic elevation of TnT in HD. However, the magnitude of TnT change in HD that is clinically relevant both for myocardial infaction diagnosis and for the worsening of chronic cardiac disease remains to be defined. Indeed, some parameters including renal removal impairment, adsorption onto dialyzer membranes or change in troponin molecular structure could influence TnT levels. In our study we investigated the influence of a single dialysis session on troponin T levels using a high sensitive assay (TnTHS). METHODS: We included 93 patients without cardiovascular acute events (M 54%; W 46%) with a mean age of 65.1615.5 years. Diabetes was present in 1/3 of our population and 2/3 of patients showed a past history of cardiovascular comorbidity (CC 
